RAPT   $58.02  0.07% Market Closed

RAPT Therapeutics, Inc.
Total Cash 114.84M
totalCashPerShare 3.29
EBITDA -127.72M
Total Debt 5.73M
quickRatio 7.759
currentRatio 8.141
Total Revenue
debtToEquity 5.244
Revenue/Share
ROA -0.46339
ROE -0.77975
grossProfits
freeCashflow -64.13M
operatingCashflow -104.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -23.60M
forwardPE -1.4391534
floatShares 31.55M
sharesOutstanding 34.90M
sharesShort 2.87M
sharesShortPriorMonth 3.41M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.93%
Short Ratio help_outline 11.13%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 3.129
Price To Book help_outline 0.87
earningsQuarterlyGrowth
netIncomeToCommon -120.43M
trailingEps -3.13%
forwardEps -1.89%
enterpriseToEbitda 0.18
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.56 3Q 2024
institutionsCount 152
lastUpdated Nov. 7, 2024, 3:02 a.m.